Works matching DE "URICOSURIC agents"

Results: 77

Get on top of gout with a fresh look at treatment options.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 3, p. 115, doi. 10.1007/s40267-024-01063-y

By:

Fenton, Caroline;
Kang, Connie

Publication type:

Article

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.

Published in:

Clinical Rheumatology, 2007, v. 26, n. 9, p. 1459, doi. 10.1007/s10067-006-0528-3

By:

Reinders, Mattheus K.;
van Roon, Eric N.;
Houtman, Pieternella M.;
Brouwers, Jacobus R. B. J.;
Jansen, Tim L. Th. A.

Publication type:

Article

Lesinurad: what the nephrologist should know.

Published in:

Clinical Kidney Journal, 2017, v. 10, n. 5, p. 679, doi. 10.1093/ckj/sfx036

By:

Sanchez-Niño, Maria Dolores;
Binbin Zheng-Lin;
Valiño-Rivas, Lara;
Sanz, Ana Belen;
Ramos, Adrian Mario;
Luño, Jose;
Goicoechea, Marian;
Ortiz, Alberto

Publication type:

Article

Lipophilic Extract and Tanshinone IIA Derived from Salvia miltiorrhiza Attenuate Uric Acid Nephropathy through Suppressing Oxidative Stress-Activated MAPK Pathways.

Published in:

American Journal of Chinese Medicine, 2020, v. 48, n. 6, p. 1455, doi. 10.1142/S0192415X20500718

By:

Zhang, Xiao-Wei;
Zhou, Mei;
An, Lin;
Zhang, Ping;
Li, Ping;
Chen, Jun

Publication type:

Article

Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review.

Published in:

Drugs, 2023, v. 83, n. 16, p. 1501, doi. 10.1007/s40265-023-01944-y

By:

Terkeltaub, Robert

Publication type:

Article

Lesinurad: First Global Approval.

Published in:

Drugs, 2016, v. 76, n. 4, p. 509, doi. 10.1007/s40265-016-0550-y

By:

Hoy, Sheridan

Publication type:

Article

Difficult-to-Treat Gouty Arthritis: A Disease Warranting Better Management.

Published in:

2011

By:

Schlesinser, Naomi

Publication type:

Journal Article

Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.

Published in:

Journal of Primary Health Care, 2019, v. 11, n. 2, p. 117, doi. 10.1071/HC18082

By:

Lawrence, Aniva;
Scott, Sharon;
Saparelli, Fabio;
Greville, Georgina;
Miller, Andrew;
Taylor, Andrea;
Gow, Peter

Publication type:

Article

A 'complexity' of urate transporters.

Published in:

2010

By:

Wright AF;
Rudan I;
Hastie ND;
Campbell H;
Wright, Alan F;
Rudan, Igor;
Hastie, Nicholas D;
Campbell, Harry

Publication type:

journal article

Safety, Efficacy, and Pharmacokinetics of HP501 in Healthy Volunteers and Hyperuricemic Patients: A Phase I/IIa Study.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 6, p. 1667, doi. 10.1210/clinem/dgac032

By:

Zhenlei Wang;
Xinghai Li;
Ying Jin;
Runhan Liu;
Xiangjie Di;
Yi Zhou;
Ying Wang;
Lei Fan;
Yuanwei Chen;
Yongsheng Wang;
Li Zheng

Publication type:

Article

Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.

Published in:

2021

By:

Stack, Austin G.;
Han, David;
Goldwater, Ronald;
Johansson, Susanne;
Dronamraju, Nalina;
Oscarsson, Jan;
Johnsson, Eva;
Parkinson, Joanna;
Erlandsson, Fredrik

Publication type:

journal article

Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.

Published in:

Nephrology Dialysis Transplantation, 2013, v. 28, n. 3, p. 603, doi. 10.1093/ndt/gfs574

By:

Nakanishi, Takeo;
Ohya, Kouhei;
Shimada, Sho;
Anzai, Naohiko;
Tamai, Ikumi

Publication type:

Article

On the Possible Chemical Justification of the Ethnobotanical Use of Hyptis obtusiflora in Amazonian Ecuador.

Published in:

Plants (2223-7747), 2018, v. 7, n. 4, p. 104, doi. 10.3390/plants7040104

By:

Luzuriaga-Quichimbo, Carmen X.;
Blanco-Salas, José;
Cerón-Martínez, Carlos E.;
Stanković, Milan S.;
Ruiz-Téllez, Trinidad

Publication type:

Article

Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.

Published in:

International Journal for Equity in Health, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12939-021-01601-4

By:

Ofanoa, Malakai;
Ofanoa, Samuela Malakai;
Heather, Maryann;
Tu'akoi, Siobhan;
Lutui, Hinamaha;
Dalbeth, Nicola;
Grey, Corina;
van der Werf, Bert;
Goodyear-Smith, Felicity

Publication type:

Article

The management of gout.

Published in:

Australian Prescriber, 2016, v. 39, n. 4, p. 119, doi. 10.18773/austprescr.2016.047

By:

Finch, Andrew;
Kubler, Paul

Publication type:

Article

Individualized homeopathic medicines and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic, pilot trial.

Published in:

Journal of Complementary & Integrative Medicine, 2021, v. 18, n. 3, p. 599, doi. 10.1515/jcim-2020-0129

By:

Nayak, Chintamani;
Pattanaik, Nivedita;
Chattopadhyay, Abhijit;
Misra, Pankhuri;
Bhar, Koushik;
Michael, James;
Koley, Munmun;
Saha, Subhranil

Publication type:

Article

International position paper on the appropriate use of uricosurics with the introduction of lesinurad.

Published in:

Clinical Rheumatology, 2018, v. 37, n. 12, p. 3159, doi. 10.1007/s10067-018-4306-9

By:

Jansen, Tim L.;
Perez-Ruiz, Fernando;
Tausche, Anne-Kathrin;
Richette, Pascal

Publication type:

Article

Influence of urate-lowering therapies on renal handling of uric acid.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 1, p. 133, doi. 10.1007/s10067-014-2806-9

By:

Ma, Lili;
Wei, Lei;
Chen, Huiyong;
Zhang, Zhuojun;
Yu, Qiang;
Ji, Zongfei;
Jiang, Lindi

Publication type:

Article

Efficacy and safety of urate‐lowering treatments in patients with hyperuricemia: A comprehensive network meta‐analysis of randomized controlled trials.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 4, p. 729, doi. 10.1111/jcpt.13156

By:

Sun, Shan‐Shan;
Zhang, Dong‐Hu;
Shi, Yue;
Lin, Cheng‐Jiang;
Lin, Jian‐Yang

Publication type:

Article

Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients.

Published in:

Blood Pressure, 2011, v. 20, n. 2, p. 104, doi. 10.3109/08037051.2010.532323

By:

Kostka-Jeziorny, Katarzyna;
Uruski, Paweł;
Tykarski, Andrzej

Publication type:

Article

Emerging uricosurics for gout.

Published in:

2017

By:

Terkeltaub, Robert

Publication type:

Video Game Review

Probenecid potentiates MPTP/ MPP+ toxicity by interference with cellular energy metabolism.

Published in:

Journal of Neurochemistry, 2013, v. 127, n. 6, p. 782, doi. 10.1111/jnc.12343

By:

Alvarez‐Fischer, Daniel;
Noelker, Carmen;
Grünewald, Anne;
Vulinović, Franca;
Guerreiro, Serge;
Fuchs, Julia;
Lu, Lixia;
Lombès, Anne;
Hirsch, Etienne C.;
Oertel, Wolfgang H.;
Michel, Patrick P.;
Hartmann, Andreas

Publication type:

Article

Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.

Published in:

2001

By:

Salzer, Wanda;
Widemann, Brigitte;
McCully, Cynthia;
Adamson, Peter C.;
Balis, Frank M.;
Salzer, W;
Widemann, B;
McCully, C;
Adamson, P C;
Balis, F M

Publication type:

journal article

Urate-Lowering Therapy: Current Options and Future Prospects for Elderly Patients with Gout.

Published in:

Drugs & Aging, 2014, v. 31, n. 11, p. 777, doi. 10.1007/s40266-014-0214-0

By:

Stamp, Lisa;
Chapman, Peter

Publication type:

Article

The Challenges of Gout Management in the Elderly.

Published in:

Drugs & Aging, 2011, v. 28, n. 8, p. 591, doi. 10.2165/11592750-000000000-00000

By:

Stamp, Lisa K.;
Jordan, Sarah

Publication type:

Article

Probenecid Pre-treatment Downregulates the Kidney Cl-/HCO3- Exchanger (Pendrin) and Potentiates Hydrochlorothiazide-Induced Diuresis.

Published in:

Frontiers in Physiology, 2018, p. N.PAG, doi. 10.3389/fphys.2018.00849

By:

Barone, Sharon;
Xu, Jie;
Zahedi, Kamyar;
Brooks, Marybeth;
Soleimani, Manoocher

Publication type:

Article

Treatment Options for Gout.

Published in:

Deutsches Ärzteblatt International, 2017, v. 114, n. 13, p. 215, doi. 10.3238/arztebl.2017.0215

By:

Engel, Bettina;
Just, Johannes;
Bleckwenn, Markus;
Weckbecker, Klaus

Publication type:

Article

RASBURICASE NO TRATAMENTO DE GOTA TOFÁCEA.

Published in:

Acta Reumatológica Portuguesa, 2009, v. 34, n. 3, p. 551

By:

Ribeiro, Ana;
Bogas, Mónica;
Costa, José;
LúciaCosta;
Araújo, Domingos

Publication type:

Article

Is Febuxostat Use Associated With Increased Risk of Cardiovascular Disease Events? The Answer Is Crystal Clear.

Published in:

2021

By:

Charlton, Alexandra;
MacMullan, Paul Anthony

Publication type:

Editorial

Activating Effect of Benzbromarone, a Uricosuric Drug, on Peroxisome Proliferator-Activated Receptors.

Published in:

PPAR Research, 2007, p. 1, doi. 10.1155/2007/36092

By:

Kunishima, Chiyoko;
Inoue, Ikuo;
Oikawa, Toshihiro;
Nakajima, Hiromu;
Komoda, Tsugikazu;
Katayama, Shigehiro

Publication type:

Article

Efficacy and Safety of Lesinurad in Patients with Hyperuricemia Associated with Gout: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials.

Published in:

Pharmacotherapy, 2018, v. 38, n. 11, p. 1106, doi. 10.1002/phar.2183

By:

Wu, Jie‐Ying;
Chang, Ya‐Ting;
Lin, Ying‐Chin;
Lee, Chia‐Hwa;
Loh, El‐Wui;
Wu, Mei‐Yi;
Chang, Yu‐Sheng;
Tam, Ka‐Wai

Publication type:

Article

Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 142, doi. 10.1111/bcp.13427

By:

Hill‐McManus, Daniel;
Soto, Elena;
Marshall, Scott;
Lane, Steven;
Hughes, Dyfrig

Publication type:

Article

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?

Published in:

Drug Safety, 2008, v. 31, n. 8, p. 643, doi. 10.2165/00002018-200831080-00002

By:

Lee, Ming-Han H.;
Graham, Garry G.;
Williams, Kenneth M.;
O^Day, Richard

Publication type:

Article

Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients.

Published in:

International Journal of Rheumatology, 2014, p. 1, doi. 10.1155/2014/263720

By:

Azevedo, Valderilio Feijó;
Buiar, Pedro Grachinski;
Giovanella, Laura Helena;
Severo, Carolina Rossetti;
Carvalho, Mauricio

Publication type:

Article

Approach To the Treatment of Hyperuricemia.

Published in:

Medicine & Health Rhode Island, 2009, v. 92, n. 11, p. 359

By:

Poon, Samuel H.;
Hall, Harald A.;
Zimmermann, Bernard

Publication type:

Article

Impact of uricosurics on mortality outcomes in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.

Published in:

International Journal of Pharmacy Practice, 2024, v. 32, n. 3, p. 259, doi. 10.1093/ijpp/riae003

By:

Kow, Chia Siang;
Ramachandram, Dinesh Sangarran;
Hasan, Syed Shahzad;
Thiruchelvam, Kaeshaelya

Publication type:

Article

Managing gout: not a trivial matter.

Published in:

Practice Nursing, 2013, v. 24, n. 4, p. 179, doi. 10.12968/pnur.2013.24.4.179

By:

Finney, Diana

Publication type:

Article

The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.

Published in:

Internal Medicine Journal, 2016, v. 46, n. 9, p. 1075, doi. 10.1111/imj.13173

By:

Stamp, L. K.;
Haslett, J.;
Frampton, C.;
White, D.;
Gardner, D.;
Stebbings, S.;
Taylor, G.;
Grainger, R.;
Kumar, R.;
Kumar, S.;
Kain, T.;
Porter, D.;
Corkill, M.;
Cathro, A.;
Metcalfe, S.;
Wyeth, J.;
Dalbeth, N.

Publication type:

Article

Management of gout: beyond allopurinol.

Published in:

Internal Medicine Journal, 2010, v. 40, n. 8, p. 545, doi. 10.1111/j.1445-5994.2010.02293.x

By:

McGill, N. W.

Publication type:

Article

Utilization of allopurinol in the Australian community.

Published in:

Internal Medicine Journal, 2008, v. 38, n. 6a, p. 388, doi. 10.1111/j.1445-5994.2008.01641.x

By:

Chung, Y.;
Lu, C. Y.;
Graham, G. G.;
Mant, A.;
Day, R. O.

Publication type:

Article

Comparative Study of Real-Life Management Strategies in Gout: Data From Two Protocolized Gout Clinics.

Published in:

2020

By:

Kampe, R.;
Durme, C.;
Janssen, M.;
Eijk‐Hustings, Y.;
Boonen, A.;
Jansen, T. L.;
Te Kampe, R;
van Durme, C;
van Eijk-Hustings, Y

Publication type:

journal article

Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice.

Published in:

Acta Pharmacologica Sinica, 2013, v. 34, n. 11, p. 1397, doi. 10.1038/aps.2013.97

By:

Cai, Hai-yan;
Wang, Ting;
Zhao, Jian-chun;
Sun, Peng;
Yan, Gui-rui;
Ding, Hai-peng;
Li, Ying-xia;
Wang, He-yao;
Zhu, Wei-liang;
Chen, Kai-xian

Publication type:

Article

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.

Published in:

Rheumatology International, 2017, v. 37, n. 9, p. 1435, doi. 10.1007/s00296-017-3777-3

By:

Janssen, Carly;
Jansen, Tim;
Oude Voshaar, Martijn;
Vonkeman, Harald;
van de Laar, Mart

Publication type:

Article

Musculoskeletal Ultrasound in Monitoring the Efficacy of Gout: A Prospective Study Based on Tophus and Double Contour Sign.

Published in:

Balkan Medical Journal, 2023, v. 40, n. 2, p. 104, doi. 10.4274/balkanmedj.galenos.2022.2022-7-39

By:

Hongmei Yuan;
Yuhong Fan;
Xurong Mou;
Yufeng Qing;
Xiang Yan;
Xuemei Tang;
Wensheng Yue;
Peng Gu;
Qibin Yang;
Yonglong He

Publication type:

Article

PI-23.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P13, doi. 10.1016/j.clpt.2005.12.044

By:

Uchida, S.;
Shimada, K.;
Misaka, S.;
Yan, D.;
Li, X.;
Nishio, S.;
Imai, H.;
Ohashi, K.;
Yamada, S.;
Watanabe, H.

Publication type:

Article

The History and Future of Probenecid.

Published in:

Cardiovascular Toxicology, 2012, v. 12, n. 1, p. 1, doi. 10.1007/s12012-011-9145-8

By:

Robbins, Nathan;
Koch, Sheryl;
Tranter, Michael;
Rubinstein, Jack

Publication type:

Article

Uricosuric Action of Losartan via the Inhibition of Urate Transporter 1 (URAT1) in Hypertensive Patients.

Published in:

American Journal of Hypertension, 2008, v. 21, n. 10, p. 1157, doi. 10.1038/ajh.2008.245

By:

Hamada, Toshihiro;
Ichida, Kimiyoshi;
Hosoyamada, Makoto;
Mizuta, Einosuke;
Yanagihara, Kiyotaka;
Sonoyama, Kazuhiko;
Sugihara, Shinobu;
Igawa, Osamu;
Hosoya, Tatsuo;
Ohtahara, Akira;
Shigamasa, Chiaki;
Yamamoto, Yasutaka;
Ninomiya, Haruaki;
Hisatome, Ichiro

Publication type:

Article

SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney.

Published in:

Pflügers Archiv: European Journal of Physiology, 2018, v. 470, n. 12, p. 1739, doi. 10.1007/s00424-018-2190-4

By:

Auberson, Muriel;
Stadelmann, Sophie;
Stoudmann, Candice;
Seuwen, Klaus;
Koesters, Robert;
Thorens, Bernard;
Bonny, Olivier

Publication type:

Article

Uricosuric agents decrease the plasma urate level in rats by concomitant treatment with topiroxostat, a novel xanthine oxidoreductase inhibitor.

Published in:

Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 1, p. 76, doi. 10.1111/jphp.12490

By:

Taniguchi, Tetsuya;
Ashizawa, Naoki;
Matsumoto, Koji;
Iwanaga, Takashi;
Saitoh, Kazuhiro

Publication type:

Article

Reply.

Published in:

Arthritis & Rheumatology, 2023, v. 75, n. 9, p. 1681, doi. 10.1002/art.42494

By:

Xue, Xiaomei;
Yan, Fei;
Guo, Kai;
He, Yuwei;
Li, Changgui

Publication type:

Article